N,N'-Desethylene-N,N'-diforMyl Levofloxacin
|
左氧氟沙星杂质
|
151377-74-1
|
Trelagliptin IMpurity
|
曲格列汀杂质
|
77532-85-5
|
Iptazosole impurity
|
依匹唑哌杂质
|
|
Cefixime Impurity
|
头孢克肟杂质
|
33748-00-4
|
Linagliptin iMpurity
|
利拉利汀杂质
|
2140263-92-7
|
LevetiracetaM IMurity (L-2-AMinobutanaMide HCl,S-2-AMinobutanaMide HCl)
|
左乙拉西坦杂质
|
1933471-30-7
|
Canagliflozin iMpurity
|
卡格列净杂质
|
|
Cefaclor EP IMpurity
|
头孢克洛杂质
|
|
LCZ Impurity
|
LCZ696杂质
|
753421-85-1
|
EveroliMus iMpurity
|
依维莫司杂质
|
1661009-29-5
|
6,8-DIBROMO-3-CYCLOHEXYL-3,4-DIHYDRO-2(1H)-QUINAZOLINONE
|
盐酸溴己新杂质
|
21237-84-3
|
Methanesulfonate methanesulfonamide impurity
|
甲磺酸沙芬酰胺杂质
|
|
Cinacalcet IMpurity
|
西那卡塞杂质
|
1229224-93-4
|
Crizotinib iMpurity
|
克唑替尼杂质
|
|
Afatinib impurity
|
阿法替尼杂质
|
|
6-?amino-7-[(tetrahydro-3-furanyl)oxy]-4(3H)-Quinazolinone
|
阿法替尼杂质
|
1405180-57-5
|
Lurasidon hydrochloride iMpurity
|
鲁拉西酮杂质
|
1260138-03-1
|
Cefoxitin Impurity
|
头孢西丁杂质
|
|
Lenalidomide impurity (spot)
|
来那度胺杂质 (现货)
|
|
AMlodipine iMpurity
|
氨氯地平杂质
|
|
Pabuxilibu impurities
|
帕布昔利布杂质
|
|
NA
|
双嘧达莫杂质对照品
|
|
RaMelteon iMpurity
|
雷美替胺杂质
|
1204581-51-0
|
Edoxaban iMpurities
|
依度沙班杂质
|
1255529-34-0
|
Pabuximab impurity
|
帕布昔利布杂质
|
|
NA
|
转基因大豆标准品
|
|
BroMhexine Hydrochloride iMpurity DN-(2-AMino-5-broMobenzyl)-N-MethylcyclohexanaMine Dihydrochloride
|
溴己新杂质
|
132004-28-5
|
Paroxetine IMpurity
|
帕罗西汀杂质
|
|
IMatinib iMpurity
|
伊马替尼杂质
|
152459-96-6
|
Erythromycin Impurity
|
红霉素杂质
|
40554-78-7
|